Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4 — Ocoee, Florida

Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4 is a clinical research site located in Ocoee, Florida, United States.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4 has participated in 2 clinical trials.

Therapeutic areas: Solid Tumor and Hematologic Malignancies, Chronic Myelogenous Leukemia.

Sponsors: Pfizer, Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Ocoee

Browse all research sites in Florida · View every site in Ocoee

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4?

Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4 conducted?

Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4 has 2 clinical trials on record. Their work covers Solid Tumor and Hematologic Malignancies, Chronic Myelogenous Leukemia.

Is Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4 accredited by Crixeo Clinical Trials?

Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.